Study to Evaluate the Efficacy and Safety of Oral CT1812 in Participants With Geographic Atrophy (GA) Secondary to Dry Age-Related Macular Degeneration (AMD).
Clinical trial NCT05893537 · TERMINATED
Trial details
- NCT number
- NCT05893537
- Sponsor
- Cognition Therapeutics
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-16
- Primary completion
- 2025-03-04
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.